DOI: 10.1111/nicc.70758 ISSN: 1362-1017

Effectiveness of Tomazoni Measurement Method for Central Catheter Tip Positioning in Neonates: A Randomised Controlled Trial

Giulia Ribeiro Schettino Regne, Catharine Galvão Diniz, Denise Miyuki Kusahara, Luciano Marques dos Santos, Patrícia Kuerten Rocha, Bruna Figueiredo Manzo

ABSTRACT

Background

Accurate peripherally inserted central catheter ( PICC ) tip positioning in neonates remains challenging, with high rates of malposition reported using traditional measurement methods.

Aim

To evaluate the effectiveness of the Tomazoni method for PICC positioning in neonates compared with the traditional method.

Study Design

Pragmatic, parallel‐group randomised clinical trial with stratified block randomisation, conducted in a neonatal intensive care unit in Brazil between June 2024 and April 2025.

Results

Of 62 randomised procedures, 55 were evaluable (27 in the experimental group, 28 in the control group). Central positioning was achieved in 21 of 27 procedures (77.8%) in the experimental group versus 5 of 28 (17.9%) in the control group ( p  < 0.001). PICC insertion procedures assessed using the Tomazoni method were 4.36 times more likely to achieve central tip placement ( RR  = 4.36; 95% CI : 1.91–9.88). Catheter withdrawal was required in 3 of 27 procedures (11.1%) in the experimental group versus 16 of 28 (57.1%) in the control group ( p  = 0.001; RR  = 0.19; 95% CI : 0.06–0.59).

Conclusions

The Tomazoni measurement method was associated with substantially higher rates of central PICC tip positioning and reduced need for catheter withdrawal compared with the traditional method.

Relevance to Clinical Practice

The Tomazoni method offers a reproducible, low‐cost measurement strategy that can be implemented in neonatal intensive care units to improve catheter positioning accuracy and reduce procedure‐related manipulations, with potential implications for patient safety. The trial, titled ‘Comparison between measurements of peripherally inserted central catheters in children and newborns’, was registered in the Brazilian Clinical Trials Registry under the identifier RBR ‐55zwb45.

Trial Registration

This trial is registered in the Brazilian Clinical Trials Registry (ReBEC) under the identifier RBR‐55zwb45

More from our Archive